National Centre for Clinical Research on Emerging Drugs (NCCRED)

Registrations are now open for our 2024 Symposium - Innovations: Improving health outcomes for people who use methamphetamine and emerging drugs. Register here: https://lnkd.in/g7vCbHiC

Register for our next webinar: GHB insights for service providers This webinar will cover what GHB is and why people use it, as well as recent learnings from research, including:   🔹 changing demographics in GHB use   🔹 harm reduction learnings   🔹 withdrawal management  Sign up: https://lnkd.in/gkPCDWPd  

Our most recent webinar explores the role of family and friends in treatments for methamphetamine use, including the latest evidence base and suggestions for how the AOD can better support family and friends. You can watch the recording and see relevant resources here: https://lnkd.in/gupVdBxe

Our Director Nadine Ezard contributed to last week's coverage on the ABC about increasing harms from nitazenes in Australia.   Nitazenes are a group of highly potent synthetic opioids, up to 1000 times more potent than morphine by some measures, and have been found in Australia in several substances, including heroin, MDMA and cocaine.   Watch the report: https://lnkd.in/gjgAqJf8  

We are recruiting for a Clinical Project Manager! This role will manage a multi-centre randomised controlled clinical trial, and is responsible for developing trial procedures, designing study collateral and the implementation of the study across at least 6 sites. Find out more and apply:

Please share with your contacts or let us know if you know anywhere or anyone who may be interested in knowing more about this trial!

Researchers at St Vincent’s Hospital Sydney and UNSW are looking for people over the age of 18 who use methamphetamine to be involved in a clinical trial with a new medication. The NABU study will be trialling an oral naltrexone-bupropion combination medication for methamphetamine use disorder. To express interest in the study please follow the link: https://lnkd.in/gmiTJqKA     For further information regarding the trial please contact: Email: [email protected] Phone: 0436 613 342   NABU Pilot Recruitment Social Media Text Version 1.0 dated 08 April 2024

Join us for a webinar next month about working with the families and friends of people who use methamphetamine, featuring a presentation from Clare Rushton (University of Wollongong and NSW Health.) Sign up: https://lnkd.in/gZu3YuJQ

There is growing evidence of harms due to nitazenes in Australia. Nitazenes are a group of highly potent synthetic opioids, up to 1000 times more potent than morphine by some measures. Our new briefing covers the origins of nitazenes, their presence and impact in Australia, and an overview of harm reduction strategies to respond to them: https://lnkd.in/gudnk97G

We are hosting a webinar next week about Australian preparedness for nitazenes, a group of highly potent synthetic opioids. We will be joined by two colleagues from Ireland, who will be discussing a cluster of overdoses that occurred in Ireland last year after an influx of nitazenes on the market. Sign up: https://lnkd.in/eZX7nsZU